<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(6)</volume><submitter>Dhondt A</submitter><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Low molecular weight heparins (LMWHs) are small enough to pass large pore dialysis membranes. Removal of LMWH if injected before the start of the session is possible during high-flux dialysis and hemodiafiltration. The aim of this study was to determine the optimal mode (place and time) of tinzaparin administration during postdilution hemodiafiltration.&lt;h4>Study design, setting, patients&lt;/h4>In 13 chronic hemodiafiltration patients, 3 approaches of injection were compared in a randomised cross over trial: i) before the start of the session at the inlet blood line filled with rinsing solution (IN0), ii) 5 min after the start at the inlet line filled with blood (IN5) and iii) before the start of the session at the outlet blood line (OUT0). Anti-Xa activity, t</pubmed_abstract><journal>PloS one</journal><pagination>e0128634</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4468116</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial.</pubmed_title><pmcid>PMC4468116</pmcid><pubmed_authors>Glorieux G</pubmed_authors><pubmed_authors>Vanholder R</pubmed_authors><pubmed_authors>Eloot S</pubmed_authors><pubmed_authors>Dhondt A</pubmed_authors><pubmed_authors>Pauwels R</pubmed_authors><pubmed_authors>Devreese K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial.</name><description>&lt;h4>Background and objective&lt;/h4>Low molecular weight heparins (LMWHs) are small enough to pass large pore dialysis membranes. Removal of LMWH if injected before the start of the session is possible during high-flux dialysis and hemodiafiltration. The aim of this study was to determine the optimal mode (place and time) of tinzaparin administration during postdilution hemodiafiltration.&lt;h4>Study design, setting, patients&lt;/h4>In 13 chronic hemodiafiltration patients, 3 approaches of injection were compared in a randomised cross over trial: i) before the start of the session at the inlet blood line filled with rinsing solution (IN0), ii) 5 min after the start at the inlet line filled with blood (IN5) and iii) before the start of the session at the outlet blood line (OUT0). Anti-Xa activity, t</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-05-30T08:37:08.264Z</modification><creation>2019-03-26T23:33:17Z</creation></dates><accession>S-EPMC4468116</accession><cross_references><pubmed>26076014</pubmed><doi>10.1371/journal.pone.0128634</doi></cross_references></HashMap>